199 related articles for article (PubMed ID: 21418545)
1. Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression.
Soo JK; Mackenzie Ross AD; Kallenberg DM; Milagre C; Heung Chong W; Chow J; Hill L; Hoare S; Collinson RS; Hossain M; Keith WN; Marais R; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):490-503. PubMed ID: 21418545
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tubulin β-3 as a novel senescence-associated gene in melanocytic malignant transformation.
Orfanidis K; Wäster P; Lundmark K; Rosdahl I; Öllinger K
Pigment Cell Melanoma Res; 2017 Mar; 30(2):243-254. PubMed ID: 28024114
[TBL] [Abstract][Full Text] [Related]
3. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
Richmond A; Fine R; Murray D; Lawson DH; Priest JH
J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
[TBL] [Abstract][Full Text] [Related]
4. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
[TBL] [Abstract][Full Text] [Related]
5. Genetics of melanoma progression: the rise and fall of cell senescence.
Bennett DC
Pigment Cell Melanoma Res; 2016 Mar; 29(2):122-40. PubMed ID: 26386262
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
7. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
8. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
[TBL] [Abstract][Full Text] [Related]
9. p15 Expression Differentiates Nevus from Melanoma.
Taylor LA; O'Day C; Dentchev T; Hood K; Chu EY; Ridky TW; Seykora JT
Am J Pathol; 2016 Dec; 186(12):3094-3099. PubMed ID: 27855847
[TBL] [Abstract][Full Text] [Related]
10. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
[TBL] [Abstract][Full Text] [Related]
12. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.
Sviderskaya EV; Gray-Schopfer VC; Hill SP; Smit NP; Evans-Whipp TJ; Bond J; Hill L; Bataille V; Peters G; Kipling D; Wynford-Thomas D; Bennett DC
J Natl Cancer Inst; 2003 May; 95(10):723-32. PubMed ID: 12759390
[TBL] [Abstract][Full Text] [Related]
13. Absence of distinguishing senescence traits in human melanocytic nevi.
Tran SL; Haferkamp S; Scurr LL; Gowrishankar K; Becker TM; Desilva C; Thompson JF; Scolyer RA; Kefford RF; Rizos H
J Invest Dermatol; 2012 Sep; 132(9):2226-34. PubMed ID: 22513787
[TBL] [Abstract][Full Text] [Related]
14. Human nevi: no longer precursors of melanomas?
Zhang G; Herlyn M
J Invest Dermatol; 2012 Sep; 132(9):2133-4. PubMed ID: 22895446
[TBL] [Abstract][Full Text] [Related]
15. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
16. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
17. Pirin inhibits cellular senescence in melanocytic cells.
Licciulli S; Luise C; Scafetta G; Capra M; Giardina G; Nuciforo P; Bosari S; Viale G; Mazzarol G; Tonelli C; Lanfrancone L; Alcalay M
Am J Pathol; 2011 May; 178(5):2397-406. PubMed ID: 21514450
[TBL] [Abstract][Full Text] [Related]
18. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
19. Telomerase Expression in a Series of Melanocytic Neoplasms.
de Unamuno Bustos B; Sahuquillo Torralba A; Moles Poveda P; Pérez Simó G; Simarro Farinos J; Llavador Ros M; Palanca Suela S; Botella Estrada R
Actas Dermosifiliogr (Engl Ed); 2019 Apr; 110(3):212-219. PubMed ID: 30591199
[TBL] [Abstract][Full Text] [Related]
20. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]